$2.18
+0.04 (+1.87%)
GENK News30 articles
UiPath Stock Jumps on AI Agent Hackathon Launch Ahead of Earnings
UiPath shares jumped 7.4% to $10.39 after launching a global hackathon for its new coding-agent platform. Trading volume spiked with heavy call option activity ahead of May 28 earnings.
Biogen Completes Apellis Takeover, Gains Rare-Disease Pipeline
Biogen has completed its acquisition of Apellis Pharmaceuticals, delisting APLS shares. Biogen gains Syfovre and Empaveli, plus a kidney disease pipeline, with a CVR tied to Syfovre sales.
Rare Hindenburg Omen Flashes Twice as Wall Street Divergence Widens
A rare market warning signal, the Hindenburg Omen, flashed twice on Wall Street as tech stocks surge while other sectors lag, despite the S&P 500 hitting a new high.
REGENXBIO Shares Tumble 37% Despite Duchenne Gene Therapy Trial Success
REGENXBIO (RGNX) stock plummeted 37% to $6.31 despite positive Phase III data for RGX-202, as two serious adverse events and FDA approval doubts overshadowed the results.
Robinhood Shares Rally as April Data Signals Retail Resurgence
Robinhood shares jumped 5.3% after April data showed platform assets rose 12% to $345.4B and net deposits hit $6B, signaling renewed retail engagement.
Biogen Completes Apellis Takeover, Ending Nasdaq Listing
Biogen closed its $5.3 billion acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and ending its Nasdaq listing.
Forgent Power Soars on Record Orders, AI Data Center Demand Drives Growth
Forgent Power Solutions raised its FY2026 revenue forecast after record Q3 bookings of $867 million, signaling robust AI data center demand. Shares jumped in premarket trading.
Precigen Surges on Papzimeos Revenue, Narrows Loss in Q1
Precigen (PGEN) shares surged 14% as Q1 revenue of $23.3M beat estimates, fueled by $21.6M from Papzimeos. Net loss narrowed to $7.9M from $54.2M a year ago.
UiPath Shares Slide as AI Agent Launch Fails to Calm Earnings Jitters
UiPath shares dropped nearly 6% after launching a new AI coding agent integration, as investors await clearer demand signals ahead of the company's May 28 earnings call.
Broadwind Soars 117% as Strategic Shift to Power Generation Reshapes Valuation
Broadwind shares surged 117% after Q1 results beat estimates and the company signaled a strategic pivot to gas-turbine and power-infrastructure work, away from wind towers.
10x Genomics Tumbles on Revenue Slide; Buffett Warns of 'Gambling Mood'
10x Genomics shares dropped 5.3% after Q1 revenue fell 2.6% year-over-year, while Warren Buffett cautioned investors against a 'gambling mood' driving unsustainable valuations.
KC-135 Tanker Emergency Over Qatar Renews Scrutiny of Aging Fleet
A US KC-135 Stratotanker declared an emergency over Qatar, highlighting the strain on the aging tanker fleet amid heightened tensions with Iran.
Genmab Shares Slide on Profit Dip Despite Strong Revenue Growth
Genmab shares tumbled nearly 10% in Copenhagen after Q1 net profit plunged to $53M, weighed down by Merus deal costs and elevated R&D, despite a 25% revenue surge to $896M.
Nebius Eyes Record Highs After $643M Eigen AI Deal, Q1 Earnings in Focus
Nebius shares hover near record highs after a $643M deal for Eigen AI, with Q1 earnings due May 13 set to test the stock's momentum.
Anthropic Unveils AI Agent Templates for Financial Sector Automation
Anthropic released 10 prebuilt AI agent templates for banks and insurers, automating pitchbooks, KYC, and accounting. FIS partners on AML agents; BMO and Amalgamated Bank pilot.
GeneDx Shares Halved After Revenue Forecast Cut, Reimbursement Woes
GeneDx stock crashed 51% after slashing its 2026 revenue outlook, as reimbursement rates and product mix weighed on first-quarter results.
Tech Rally Resurgent: Intel, Micron, SanDisk Lead Nasdaq Higher
The Nasdaq rose 0.83% Tuesday, driven by Intel, Micron, and SanDisk as AI optimism returned. Oil's pullback eased rate worries, extending April's record rally.
Netflix, Microsoft, and Others Chart Divergent Cash Strategies
Netflix adds $25B to buybacks after deal breakup; Microsoft plans $190B AI spend. PulteGroup and Mobileye also expand repurchases as stocks dip.
Nebius Shares Surge on $643 Million Eigen AI Acquisition
Nebius Group acquires Eigen AI for $643M in cash and stock, sending NBIS shares up nearly 12% as the company strengthens its AI inference capabilities.
Nebius Acquires Eigen AI for $643M to Tackle Inference Cost Challenge
Nebius Group NV acquires Eigen AI for $643M to expand AI inference software, addressing rising costs in AI cloud computing. Shares rose 11.8%.
Nebius Acquires Eigen AI for $643M to Boost Inference Capabilities
Nebius Group N.V. acquires Eigen AI for $643M to advance AI inference, with shares jumping 11.3%.
Canada Targets Crypto ATMs and Establishes Federal Financial Crimes Agency
Canada plans to ban cryptocurrency ATMs and establish a new Financial Crimes Agency with police powers, citing over C$704 million in fraud losses in 2025.
General Dynamics Soars on Strong Submarine, Jet Orders; 2026 Outlook Raised
General Dynamics shares surged 10.9% after Q1 earnings and revenue topped estimates, driven by submarine and Gulfstream jet orders, lifting its 2026 outlook.
Generac Surges on Raised 2026 Outlook as Data Center Demand Drives Growth
Generac raised its 2026 outlook after Q1 net sales rose 12%, driven by data center demand. Shares jumped 11% as adjusted EPS of $1.80 topped estimates.
Biogen Lowers 2026 Profit View Despite Q1 Beat; Leqembi Sales Soar 74%
Biogen lowered its 2026 adjusted earnings outlook to $14.25-$15.25 per share after Q1 results topped estimates. Leqembi sales jumped 74% to $168M globally.
Regeneron Q1 Results Top Estimates, Eylea Challenges Loom
Regeneron reported strong Q1 results with revenue up 19% and earnings above estimates, but Eylea sales declined and an FDA delay on a new syringe manufacturer weighs on shares.
Analysts See Divergent Paths for Microsoft, Alphabet, and Oracle in AI Cloud Race
Analysts forecast Oracle with the most upside, Microsoft facing a tough earnings bar, and Alphabet with less room to run as AI cloud spending takes center stage this earnings week.
Guggenheim Initiates Buy on Shake Shack Ahead of Q1 Earnings
Guggenheim initiated Shake Shack at Buy with a $120 target, boosting shares 5.6%. The call comes before May 7 earnings, with Q1 visits up nearly 20%.
Regeneron Stock Rises on Drug Pricing Deal, Free Gene Therapy Offer
Regeneron shares gained 2.6% Thursday following a drug-pricing pact with the U.S. and a plan to offer its new gene therapy Otarmeni at no cost. Analysts remain optimistic ahead of Q1 results.
Alphabet Unveils New AI Agents and Chips Ahead of Earnings Report
Alphabet shares traded near $340 after Google unveiled new enterprise AI software and custom chips at Cloud Next, ahead of Q1 earnings on April 29.